Literature DB >> 22302534

The use of novel hemostatic sealant (Tisseel) in laparoscopic myomectomy: a case-control study.

Roberto Angioli1, Francesco Plotti, Roberto Ricciardi, Corrado Terranova, Marzio Angelo Zullo, Patrizio Damiani, Roberto Montera, Federica Guzzo, Giuseppe Scaletta, Ludovico Muzii.   

Abstract

BACKGROUND: This is the first case-control study on the use of a fibrin sealant (Tisseel) on uterine suture during laparoscopic myomectomy (LM), with the primary endpoint to evaluate the intraoperative bleeding and postoperative blood loss. In addition, we evaluated the time required to achieve hemostasis using Tisseel and how much it can influence operative time.
METHODS: From December 2009 to January 2011, consecutive patients older than 18 years with symptomatic isolate intramural myoma with maximal diameter B6 cm and ≥ 4 cm and with a sonographically diagnosed free myometrium margin ≥ 0.5 cm were included in the study. We selected from our institute's database a group of consecutive patients with homogeneous features of the study group, who underwent laparoscopic myomectomy without Tisseel application.
RESULTS: Fifteen women with symptomatic myoma were enrolled in the study (group A). Regarding the control group (group B), we selected a homogenous group of 15 patients with the same preoperative characteristics of the study group. Mean operative time was 47.7 min and 62.1 min, for groups A and B respectively (p < 0.05). Mean time required to achieve complete haemostasis was 195.5 s in group A and 361.8 in control group B (p < 0.0001). Mean estimated blood loss was 111.3 mL and 230 mL in groups A and B, respectively (p < 0.05). Mean hemoglobin decrease was 1.36 g/dL and 2.04 g/dL in groups A and B, respectively (p < 0.05).
CONCLUSIONS: The use of Tisseel during LM may represent a valid alternative solution for obtaining hemostasis, reducing intra- and postoperative bleeding. Furthermore, it may help the surgeon to obtain a rapid healing of the injured surfaces, probably reducing the use of electrocoagulationand traumatisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302534     DOI: 10.1007/s00464-012-2154-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  50 in total

1.  FloSeal Matrix: new generation topical hemostatic sealant.

Authors:  Mehmet C Oz; Joseph F Rondinone; Narinder S Shargill
Journal:  J Card Surg       Date:  2003 Nov-Dec       Impact factor: 1.620

2.  Hemostatic efficacy and safety of TachoComb in surgery. Ready to use and rapid hemostatic agent.

Authors:  G B Agus; A V Bono; E Mira; S Olivero; A Peilowich; E Homdrum; C Benelli
Journal:  Int Surg       Date:  1996 Jul-Sep

3.  Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence.

Authors:  L Fedele; P Vercellini; S Bianchi; D Brioschi; M Dorta
Journal:  Br J Obstet Gynaecol       Date:  1990-05

Review 4.  Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.

Authors:  A Lethaby; B Vollenhoven; M Sowter
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 5.  Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management.

Authors:  T Liakakos; N Thomakos; P M Fine; C Dervenis; R L Young
Journal:  Dig Surg       Date:  2001       Impact factor: 2.588

6.  Laparoscopic intracapsular myomectomy: comparison of single versus multiple fibroids removal. An institutional experience.

Authors:  Andrea Tinelli; Antonio Malvasi; Gernot Hudelist; Carlo Cavallotti; Daniel Alberto Tsin; Thoralf Schollmeyer; Bernd Bojahr; Liselotte Mettler
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2010-10       Impact factor: 1.878

7.  Prediction of operation time for laparoscopic myomectomy by ultrasound measurements.

Authors:  Wen-Chiung Hsu; Jing-Shiang Hwang; Wen-Chun Chang; Su-Cheng Huang; Bor-Ching Sheu; Pao-Ling Torng
Journal:  Surg Endosc       Date:  2007-02-09       Impact factor: 4.584

Review 8.  The uterus and fertility.

Authors:  Elizabeth Taylor; Victor Gomel
Journal:  Fertil Steril       Date:  2007-12-21       Impact factor: 7.329

9.  Influencing factors of adhesion development and the efficacy of adhesion-preventing agents in patients undergoing laparoscopic myomectomy as evaluated by a second-look laparoscopy.

Authors:  Hiroyuki Takeuchi; Mari Kitade; Iwaho Kikuchi; Hiroto Shimanuki; Jun Kumakiri; Satoru Takeda
Journal:  Fertil Steril       Date:  2007-12-26       Impact factor: 7.329

Review 10.  Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note.

Authors:  Dilantha B Ellegala; Nicholas F Maartens; Edward R Laws
Journal:  Neurosurgery       Date:  2002-08       Impact factor: 4.654

View more
  3 in total

1.  Predictors of postoperative hemoglobin drop after laparoscopic myomectomy.

Authors:  Rafał Watrowski; Christoph Jäger; Johannes Forster
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2017-03-13       Impact factor: 1.195

2.  Systematic Review of Topical Hemostatic Agent Use in Minimally Invasive Gynecologic Surgery.

Authors:  Traci E Ito; Alexandra L Martin; Edith F Henderson; Jeremy T Gaskins; Vida M Vaughn; Shan M Biscette; Resad P Pasic
Journal:  JSLS       Date:  2018 Oct-Dec       Impact factor: 2.172

Review 3.  Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive-a Laboratory and Clinical Perspective.

Authors:  William D Spotnitz
Journal:  ISRN Surg       Date:  2014-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.